A detailed history of Allworth Financial LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 156 shares of CRL stock, worth $26,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156
Previous 207 24.64%
Holding current value
$26,030
Previous $42,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$187.96 - $245.29 $9,585 - $12,509
-51 Reduced 24.64%
156 $30,000
Q2 2024

Jul 23, 2024

BUY
$206.39 - $268.73 $17,336 - $22,573
84 Added 68.29%
207 $42,000
Q1 2024

Apr 25, 2024

BUY
$203.52 - $273.43 $5,495 - $7,382
27 Added 28.13%
123 $33,000
Q4 2023

Jan 24, 2024

BUY
$164.52 - $238.84 $4,771 - $6,926
29 Added 43.28%
96 $22,000
Q3 2023

Oct 31, 2023

SELL
$194.44 - $217.61 $9,138 - $10,227
-47 Reduced 41.23%
67 $13,000
Q2 2023

Jul 18, 2023

BUY
$183.71 - $210.25 $14,329 - $16,399
78 Added 216.67%
114 $23,000
Q1 2023

Apr 18, 2023

SELL
$191.89 - $259.92 $25,329 - $34,309
-132 Reduced 78.57%
36 $7,000
Q4 2022

Jan 13, 2023

BUY
$197.11 - $250.07 $12,417 - $15,754
63 Added 60.0%
168 $0
Q3 2022

Oct 18, 2022

SELL
$182.44 - $250.54 $34,481 - $47,352
-189 Reduced 64.29%
105 $21,000
Q2 2022

Jul 13, 2022

BUY
$204.13 - $302.4 $2,857 - $4,233
14 Added 5.0%
294 $63,000
Q1 2022

Apr 22, 2022

SELL
$255.51 - $362.11 $17,885 - $25,347
-70 Reduced 20.0%
280 $80,000
Q4 2021

Jan 21, 2022

BUY
$351.38 - $448.68 $3,513 - $4,486
10 Added 2.94%
350 $132,000
Q3 2021

Nov 02, 2021

BUY
$372.64 - $458.3 $126,697 - $155,822
340 New
340 $140,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.